BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 31317203)

  • 1. Pulmonary hypertension in HFpEF and HFrEF: Pathophysiology, diagnosis, treatment approaches.
    Rosenkranz S; Kramer T; Gerhardt F; Opitz C; Olsson KM; Hoeper MM
    Herz; 2019 Sep; 44(6):483-490. PubMed ID: 31317203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension.
    Kramer T; Dumitrescu D; Gerhardt F; Orlova K; Ten Freyhaus H; Hellmich M; Baldus S; Rosenkranz S
    Int J Cardiol; 2019 May; 283():152-158. PubMed ID: 30777406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
    Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Adir Y; Guazzi M; Offer A; Temporelli PL; Cannito A; Ghio S
    Am Heart J; 2017 Oct; 192():120-127. PubMed ID: 28938958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined post- and pre-capillary pulmonary hypertension in heart failure with preserved ejection fraction.
    Dixon DD; Trivedi A; Shah SJ
    Heart Fail Rev; 2016 May; 21(3):285-97. PubMed ID: 26714826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease.
    Gorter TM; Obokata M; Reddy YNV; Melenovsky V; Borlaug BA
    Eur Heart J; 2018 Aug; 39(30):2825-2835. PubMed ID: 29947750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management.
    Ltaief Z; Yerly P; Liaudet L
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cine MRI characterizes HFpEF and HFrEF in post-capillary pulmonary hypertension.
    Lin K; Sarnari R; Pathrose A; Gordon DZ; Blaisdell J; Markl M; Carr JC
    Eur J Radiol; 2021 Jun; 139():109679. PubMed ID: 33819807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.
    Vanderpool RR; Saul M; Nouraie M; Gladwin MT; Simon MA
    JAMA Cardiol; 2018 Apr; 3(4):298-306. PubMed ID: 29541759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
    Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
    J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension.
    Gorter TM; van Veldhuisen DJ; Voors AA; Hummel YM; Lam CSP; Berger RMF; van Melle JP; Hoendermis ES
    Eur Heart J Cardiovasc Imaging; 2018 Apr; 19(4):425-432. PubMed ID: 28531295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary hypertension associated with left heart disease (group 2)].
    Schmidt KH; Bikou O; Blindt R; Bruch L; Felgendreher R; Hohenforst-Schmidt W; Holt S; Ladage D; Pfeuffer-Jovic E; Rieth A; Schmeisser A; Schnitzler K; Stadler S; Steringer-Mascherbauer R; Yogeswaran A; Kuebler WM
    Pneumologie; 2023 Nov; 77(11):926-936. PubMed ID: 37963482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Hypertension Phenotype Can Be Identified in Heart Failure With Reduced Ejection Fraction Using Echocardiographic Assessment of Pulmonary Artery Pressure With Supportive Use of Pressure Reflection Variables.
    Bech-Hanssen O; Smith JG; Astengo M; Bollano E; Bobbio E; Polte CL; Bergh N; Karason K
    J Am Soc Echocardiogr; 2023 Jun; 36(6):604-614. PubMed ID: 36681129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction.
    Andersen MJ; Hwang SJ; Kane GC; Melenovsky V; Olson TP; Fetterly K; Borlaug BA
    Circ Heart Fail; 2015 May; 8(3):542-50. PubMed ID: 25857307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular heart failure and pulmonary hypertension.
    Rosenkranz S; Gibbs JS; Wachter R; De Marco T; Vonk-Noordegraaf A; Vachiéry JL
    Eur Heart J; 2016 Mar; 37(12):942-54. PubMed ID: 26508169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in World Health Organization group II pulmonary hypertension: mortality and readmission trends with systolic and preserved ejection fraction-induced pulmonary hypertension.
    Salamon JN; Kelesidis I; Msaouel P; Mazurek JA; Mannem S; Adzic A; Zolty R
    J Card Fail; 2014 Jul; 20(7):467-75. PubMed ID: 24858070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction.
    Farrero M; Blanco I; Batlle M; Santiago E; Cardona M; Vidal B; Castel MA; Sitges M; Barbera JA; Perez-Villa F
    Circ Heart Fail; 2014 Sep; 7(5):791-8. PubMed ID: 25047042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction.
    Lai YC; Wang L; Gladwin MT
    J Physiol; 2019 Feb; 597(4):1143-1156. PubMed ID: 30549058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
    Ghio S; Crimi G; Temporelli PL; Traversi E; La Rovere MT; Cannito A; Vizza D; Scelsi L; Raineri C; Guazzi M; Oltrona Visconti L
    Eur J Heart Fail; 2018 Apr; 20(4):725-734. PubMed ID: 29148140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular-Arterial Coupling and Exercise-Induced Pulmonary Hypertension During Low-Level Exercise in Heart Failure With Preserved or Reduced Ejection Fraction.
    Obokata M; Nagata Y; Kado Y; Kurabayashi M; Otsuji Y; Takeuchi M
    J Card Fail; 2017 Mar; 23(3):216-220. PubMed ID: 27737768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.